Literature DB >> 3095479

Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum.

P A Rice, H E Vayo, M R Tam, M S Blake.   

Abstract

Neisseria gonorrhoeae that resist complement-dependent killing by normal human serum (NHS) are sometimes killed by immune convalescent serum from patients recovering from disseminated gonococcal infection (DGI). In these studies, killing by immune serum was prevented or blocked by IgG isolated from NHS. Purified human IgG antibodies directed against gonococcal protein III, an antigenically conserved outer membrane protein, contained most of the blocking activity in IgG. Antibodies specific for gonococcal porin (protein I), the major outer membrane protein, displayed no blocking function. In separate experiments, immune convalescent DGI serum which did not exhibit bactericidal activity was restored to killing by selective depletion of protein III antibodies by immunoabsorption. These studies indicate that protein III antibodies in normal and immune human serum play a role in serum resistance of N. gonorrhoeae.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3095479      PMCID: PMC2188443          DOI: 10.1084/jem.164.5.1735

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  55 in total

1.  Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease.

Authors:  J M Griffiss; M A Bertram
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  A new approach (cyano-transfer) for cyanogen bromide activation of Sepharose at neutral pH, which yields activated resins, free of interfering nitrogen derivatives.

Authors:  J Kohn; M Wilchek
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

4.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

5.  Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I.

Authors:  J S Knapp; M R Tam; R C Nowinski; K K Holmes; E G Sandström
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

6.  A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies.

Authors:  W D Zollinger; J W Boslego
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

7.  Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins.

Authors:  P A Rice; D L Kasper
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

8.  Surface-exposed protein antigens of the gonococcal outer membrane.

Authors:  J Swanson
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Isolation and partial characterization of the reduction-modifiable protein of Neisseria gonorrhoeae.

Authors:  E J Lytton; M S Blake
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  80 in total

1.  Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.

Authors:  E Rosenqvist; A Musacchio; A Aase; E A Høiby; E Namork; J Kolberg; E Wedege; A Delvig; R Dalseg; T E Michaelsen; J Tommassen
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Inhibition of bactericidal activity of anticapsular antibody by nonspecific antibodies reactive with surface-exposed antigenic determinants on Actinobacillus pleuropneumoniae.

Authors:  F A Udeze; S Kadis
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

Review 3.  Gonococcal vaccines.

Authors:  E C Tramont
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1.

Authors:  J N Weiser; E C Gotschlich
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 5.  Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.

Authors:  C N Cornelissen
Journal:  Future Microbiol       Date:  2008-06       Impact factor: 3.165

6.  Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.

Authors:  B Selander; H Käyhty; E Wedege; E Holmström; L Truedsson; C Söderström; A G Sjöholm
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

7.  The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens.

Authors:  N Ferguson; R Anderson; S Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

8.  Specificity of the immune response to the group B polysaccharide of Neisseria meningitidis.

Authors:  M R Lifely; J Esdaile
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

Review 9.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.